Search research articles
Contact Us
Filters
Showing results (11-20 of 30) with videos related to
Page
of 3
Sort By:
Frontiers in Pharmacology
|
August 28, 2020
<i>CYP3A5</i> Gene-Guided Tacrolimus Treatment of Living-Donor Egyptian Kidney Transplanted Patients
Effrosyni Mendrinou, Mohamed Elsayed Mashaly, Amir Mohamed Al Okily, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 1, 2018
Prognostic Performance of the Augmented Hematopoietic Cell Transplantation-Specific Comorbidity/Age Index in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation from Alternative Graft Sources
Mahmoud Elsawy, Barry E Storer, Filippo Milano, et al.
British Journal of Haematology
|
May 7, 2015
Multi-centre validation of the prognostic value of the haematopoietic cell transplantation- specific comorbidity index among recipient of allogeneic haematopoietic cell transplantation
Mahmoud ElSawy, Barry E Storer, Michael A Pulsipher, et al.
Current Oncology (Toronto, Ont.)
|
January 27, 2026
Abstracts of the Cell Therapy Transplant Canada 2024 Annual Conference
Stephanie A Maier, Frédéric Barabé, Tobias Berg, et al.
Current Oncology (Toronto, Ont.)
|
December 22, 2022
Abstracts of the Cell Therapy Transplant Canada 2022 Annual Conference
Stephanie A Maier, Tobias Berg, Susan Berrigan, et al.
Bone Marrow Transplantation
|
January 26, 2024
Correction: Upfront allogeneic transplantation versus JAK inhibitor therapy for patients with myelofibrosis: a North American collaborative study
Dawn Maze, Murat O Arcasoy, Ryan Henrie, et al.
Bone Marrow Transplantation
|
November 8, 2023
Upfront allogeneic transplantation versus JAK inhibitor therapy for patients with myelofibrosis: a North American collaborative study
Dawn Maze, Murat O Arcasoy, Ryan Henrie, et al.
JAMA Oncology
|
September 8, 2017
Development and Validation of a Novel Acute Myeloid Leukemia-Composite Model to Estimate Risks of Mortality
Mohamed L Sorror, Barry E Storer, Amir T Fathi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 31, 2023
Safety and Efficacy of Axicabtagene Ciloleucel versus Standard of Care in Patients 65 Years of Age or Older with Relapsed/Refractory Large B-Cell Lymphoma
Jason R Westin, Frederick L Locke, Michael Dickinson, et al.
Transplantation and Cellular Therapy
|
February 27, 2024
International Recommendations for Screening and Preventative Practices for Long-Term Survivors of Transplantation and Cellular Therapy: A 2023 Update
Seth J Rotz, Neel S Bhatt, Betty K Hamilton, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 30) with videos related to
Sort By:
Page
of 3
Frontiers in Pharmacology
|
August 28, 2020
<i>CYP3A5</i> Gene-Guided Tacrolimus Treatment of Living-Donor Egyptian Kidney Transplanted Patients
Effrosyni Mendrinou, Mohamed Elsayed Mashaly, Amir Mohamed Al Okily, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 1, 2018
Prognostic Performance of the Augmented Hematopoietic Cell Transplantation-Specific Comorbidity/Age Index in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation from Alternative Graft Sources
Mahmoud Elsawy, Barry E Storer, Filippo Milano, et al.
British Journal of Haematology
|
May 7, 2015
Multi-centre validation of the prognostic value of the haematopoietic cell transplantation- specific comorbidity index among recipient of allogeneic haematopoietic cell transplantation
Mahmoud ElSawy, Barry E Storer, Michael A Pulsipher, et al.
Current Oncology (Toronto, Ont.)
|
January 27, 2026
Abstracts of the Cell Therapy Transplant Canada 2024 Annual Conference
Stephanie A Maier, Frédéric Barabé, Tobias Berg, et al.
Current Oncology (Toronto, Ont.)
|
December 22, 2022
Abstracts of the Cell Therapy Transplant Canada 2022 Annual Conference
Stephanie A Maier, Tobias Berg, Susan Berrigan, et al.
Bone Marrow Transplantation
|
January 26, 2024
Correction: Upfront allogeneic transplantation versus JAK inhibitor therapy for patients with myelofibrosis: a North American collaborative study
Dawn Maze, Murat O Arcasoy, Ryan Henrie, et al.
Bone Marrow Transplantation
|
November 8, 2023
Upfront allogeneic transplantation versus JAK inhibitor therapy for patients with myelofibrosis: a North American collaborative study
Dawn Maze, Murat O Arcasoy, Ryan Henrie, et al.
JAMA Oncology
|
September 8, 2017
Development and Validation of a Novel Acute Myeloid Leukemia-Composite Model to Estimate Risks of Mortality
Mohamed L Sorror, Barry E Storer, Amir T Fathi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 31, 2023
Safety and Efficacy of Axicabtagene Ciloleucel versus Standard of Care in Patients 65 Years of Age or Older with Relapsed/Refractory Large B-Cell Lymphoma
Jason R Westin, Frederick L Locke, Michael Dickinson, et al.
Transplantation and Cellular Therapy
|
February 27, 2024
International Recommendations for Screening and Preventative Practices for Long-Term Survivors of Transplantation and Cellular Therapy: A 2023 Update
Seth J Rotz, Neel S Bhatt, Betty K Hamilton, et al.
Page
of 3